Yogeeta Jadhav

USPTO Publishes Drug Patent And Exclusivity Study Report

Federal Circuit Considers Patentability Of Overlapping Ranges

USPTO Discusses Duty Of Disclosure And Duty Of Reasonable Inquiry

USPTO-FDA Listening Session — Voices From Patient And Patent Advocates

Claim Construction Of An Enantiomeric Chemical Structure

CAFC Finds ANDA Infringement Despite Differences Between FDA Labeling And Claim Language

PTAB Puts Method Of Treatment Patents Under The 101 Knife